In the last trading session, 61484.0 shares of the Jaguar Health Inc (NASDAQ:JAGX) were traded, and its beta was 0.76. Most recently the company’s share price was $4.49, and it changed around -$0.04 or -0.88% from the last close, which brings the market valuation of the company to $4.57M. JAGX currently trades at a discount to its 52-week high of $181.20, offering almost -3935.63% off that amount. The share price’s 52-week low was $4.02, which indicates that the current value has risen by an impressive 10.47% since then.
Jaguar Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended JAGX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Jaguar Health Inc is expected to report earnings per share of -7.13 for the current quarter.
Jaguar Health Inc (NASDAQ:JAGX) trade information
Instantly JAGX has showed a red trend with a performance of -0.88% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 6.90 on recent trading dayincreased the stock’s daily price by 34.93%. The company’s shares are currently down -82.22% year-to-date, but still down -23.64% over the last five days. On the other hand, Jaguar Health Inc (NASDAQ:JAGX) is -44.29% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $12.98, which translates to bulls needing to increase their stock price by 65.41% from its current value. Analyst projections state that JAGX is forecast to be at a low of $12.98 and a high of $12.98.
Jaguar Health Inc (JAGX) estimates and forecasts
The year-over-year growth rate is expected to be 7.42%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 3.27M in revenue for the current quarter. 1 analysts expect Jaguar Health Inc to make 3.73M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 2.72M and 3.07M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 20.18%. Forecasts for the next quarter put sales growth at 21.66%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 86.61%. Jaguar Health Inc earnings are expected to increase by 84.85% in 2025, but the outlook is positive 83.11% per year for the next five years.
JAGX Dividends
Jaguar Health Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 2.93 shares worth $13169.0, making up 0.44% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 2.38 shares worth around $10686.0, which represents about 0.35% of the total shares outstanding.
